management_team-2

management_team-2

15 September 2017

Charlie Sasorith

Charlie Sasorith

Did you like this article? Share on social networks:

Exploitant for Innovative Pharma Companies

Associated News

Ultimate Guide for European Early & Expanded Access Programs

Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...

Learn more
10 Years of commitment to treating rare diseases

Rare diseases: At the core of our mission At PharmaBlue, we’ve spent the past decade...

Learn more
10 Years of expertise in innovative therapies

Driving access to Innovative Therapies Through Strategic Partnerships Innovation is only meaningful when it reaches...

Learn more